Lemtrada and Campath Linked with Serious Types of Stroke, FDA Warns - Legal Examiner

Lemtrada and Campath Linked with Serious Types of Stroke, FDA Warns  Legal Examiner

On November 29, 2018, the FDA warned about a rare but serious life-threatening risk of stroke and artery rupture in patients taking the multiple sclerosis (MS) ...



Comments

Post a Comment

Popular posts from this blog

Orchestra BioMed™ Announces FDA Breakthrough Device Designation for Virtue® Sirolimus-Eluting Balloon for Treatment of Below-the-Knee Peripheral Artery Disease - Vascular Disease Management

Orchestra BioMed™ Announces FDA Breakthrough Device Designation for Virtue® Sirolimus-Eluting Balloon for Treatment of Below-the-Knee Peripheral Artery Disease    Vascular Disease Management First and only non-coated sirolimus-eluting angioplasty balloon system to receive Breakthrough Device designation for below-the-knee disease; Follows ...
Read more